American Diabetes Association is a nonprofit research, information, and advocacy organization that works to prevent and cure diabetes while also focusing on improving the lives of people affected by diabetes. The Company has a number of fundraising programs. The Association funds research to manage, cure and prevent diabetes (including type 1 diabetes, type 2 diabetes, gestational diabetes, and pre-diabetes); delivers services to communities; provides information for both patients and health care professionals; and advocates on behalf of people denied their rights because of diabetes.

TypePrivate
HQArlington, US
Founded1940
Size (employees)1,237 (est)
Websitediabetes.org
American Diabetes Association was founded in 1940 and is headquartered in Arlington, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at American Diabetes Association

Tracey Brown

Tracey Brown

CEO
Charlotte Carter

Charlotte Carter

CFO
John Agos

John Agos

Chief Strategy Officer
William Cefalu

William Cefalu

Chief Medical Officer, Chief Scientific Officer
Tony Chiles

Tony Chiles

Chief Information Officer
Tony Webster

Tony Webster

Chief Human Resources Officer
Show more

American Diabetes Association Office Locations

American Diabetes Association has offices in Brookfield, Washington, Seattle, Chesapeake and in 58 other locations
Arlington, US (HQ)
900 2451 Crystal Dr
Albany, US
505 5 Pine West Plaza
Anchorage, US
103 801 W Fireweed Ln
Atlanta, US
2600 Harris Tower 233 Peachtree St NW
Bala Cynwyd, US
100 150 Monument Rd
Baltimore, US
110 2002 Clipper Park Rd
Show all (63)
Report incorrect company information

American Diabetes Association Financials and Metrics

Summary Metrics

Founding Date

1940

American Diabetes Association Revenue

American Diabetes Association's revenue was reported to be $171.06 m in FY, 2016 which is a 6.2% decrease from the previous period.
USD

Revenue (FY, 2016)

171.1 m

Revenue growth (FY, 2015 - FY, 2016), %

(6.2%)

Cash (31-Dec-2016)

18.6 m
USDFY, 2014FY, 2015FY, 2016

Revenue

200.7 m182.3 m171.1 m

Revenue growth, %

(9%)(6%)

Operating expense total

188.8 m183.3 m190.7 m
USDFY, 2014FY, 2015FY, 2016

Cash

15.5 m25.1 m18.6 m

Accounts Receivable

1.4 m1.4 m1.4 m

Prepaid Expenses

4.8 m4.4 m5 m

Inventories

1.9 m2.1 m2.3 m
USDY, 2014FY, 2015FY, 2016

Depreciation and Amortization

2.8 m2.7 m3 m

Inventories

(520 k)(332 k)(607 k)

Accounts Payable

(4.9 m)5.4 m5.5 m

Cash From Operating Activities

21.5 m16.6 m(4.1 m)
USDY, 2016

Financial Leverage

1 x
Show all financial metrics

American Diabetes Association Operating Metrics

FY, 2014FY, 2015FY, 2016

Projects Supported

376 354 378

Partners (Research Institutions)

143 145 150

Total Grants Awarded

699

Patients Served per Year

877 k
Show all operating metrics

American Diabetes Association Revenue Breakdown

Embed Graph

American Diabetes Association revenue breakdown by business segment: 25.3% from Fees from exchange transactions and 74.7% from Contribution and Grants

Report incorrect company information

American Diabetes Association Online and Social Media Presence

Embed Graph
Report incorrect company information

American Diabetes Association News and Updates

Support for American Diabetes Association's® 2018 Summer Camps for Youth with Type 1 Diabetes Enables Advanced Training in New Diabetes Care Technologies

ARLINGTON, Va., Aug. 17, 2018 /PRNewswire/ -- Since 1949, the American Diabetes Association (ADA) has hosted summer camps for children and teens ages 4-17 with type 1 diabetes and their families, allowing children to simultaneously build friendships and participate in summertime...

Breakthrough Randomized Controlled Trial Demonstrating TWO2 Efficacy in Healing Diabetic Foot Ulcers Unveiled at the American Diabetes Association 78th Scientific Sessions Conference

OCEANSIDE, Calif., June 26, 2018 /PRNewswire/ -- AOTI Inc. announced today that initial results from its recently concluded Randomized Controlled Trial (RCT) demonstrating the efficacy of its patented multi-modality Topical Wound Oxygen (TWO2) homecare therapy in healing Diabetic Foot...

Renova Therapeutics Announces an Abstract to be Presented at the Late-Breaking Scientific Session of 2018 American Diabetes Association Meeting: Urocortin-2 Gene Transfer Effectively Treats Type 1 Diabetes

SAN DIEGO, June 24, 2018 /PRNewswire-USNewswire/ -- Renova™ Therapeutics, a biotechnology company developing gene and peptide-based treatments for cardiovascular and metabolic diseases, announced today that an abstract of a study in a preclinical model of type 1 diabetes was accepted as a...

Renova Therapeutics Announces an Abstract to be Presented at the Late-Breaking Scientific Session of 2018 American Diabetes Association Meeting: Urocortin-2 Gene Transfer Effectively Treats Type 1 Diabetes

SAN DIEGO, June 24, 2018 /PRNewswire-USNewswire/ -- Renova™ Therapeutics, a biotechnology company developing gene and peptide-based treatments for cardiovascular and metabolic diseases, announced today that an abstract of a study in a preclinical model of type 1 diabetes was accepted as a...

Hygieia Announces Data From Clinical Trial Evaluating The d-Nav® Insulin Guidance Service To Be Presented at the American Diabetes Association's Annual Scientific Sessions

LIVONIA, Mich., June 18, 2018 /PRNewswire/ -- Hygieia, a digital insulin enhancement company dedicated to making insulin therapy easier for everyone involved, announced today that the company will present clinical trial data evaluating the use of its d-Nav® Insulin Guidance Service among...
Report incorrect company information

American Diabetes Association Company Life and Culture

Report incorrect company information